Back to results
US 2025/0319212 A1Published application
Gadolinium-based compound, and mri contrast agent including same
AssigneeKyungpook National University Industry-Academic Cooperation Foundation
InventorsYong Min CHANG, Bo Kyung SUNG
Life of this patent
Estimating the term…
Abstract
Disclosed is a gadolinium-based compound, and an MRI contrast agent including same. The gadolinium-based compound may be a DO3A-based gadolinium compound to which 4-hydroxybenzoic acid is bound. The MRI contrast agent may include the compound. Also disclosed is a pharmaceutical composition for preventing or treating neuroinflammatory diseases, wherein the composition comprises the compound or a pharmaceutically acceptable salt thereof.
Claims15
A compound represented by a following Chemical Formula (1):
- where L is *—(CH2)x—A1—(CH2)y—A2—(CH2)z—*,
- each of x, y and z is an integer independently selected from 0 to 5,
- each of A1 and A2 is at least one structure selected from a group consisting of a single bond, *—COO—*, *—CO—*, *—NH—*, *—CH2—*, *—CONH—*and *—O—*,
- X has a structure represented by a following Chemical Formula (2):
- where*is a binding site.
2 more elements
Dependencies are inferred from the claim text.